Concord Drugs

quarterly
yearly
ParticularsJun '21Sep '21Dec '21Mar '22Jun '22
Revenue20.229.8313.4415.4612.53
Expenses18.488.7612.7115.1811.95
EBITDA1.741.070.730.280.58
EBIT1.210.500.43-0.090.19
Profit Before Tax0.800.790.580.080.25
Net Profit0.690.460.420.030.19
Financial Ratios
Operating Profit Margin8.61%10.89%5.43%1.88%4.71%
Net Profit Margin3.41%4.68%3.13%0.19%1.52%
Earning Per Share (Diluted)0.790.520.480.030.21
Dividends Per ShareNANANANANA
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.3.8
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI